The 2 analysts offering 12-month price forecasts for Harrow Health Inc have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 10.00. The median estimate represents a +70.94% increase from the last price of 5.85.
The current consensus among 2 polled investment analysts is to Buy stock in Harrow Health Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.17
Reporting Date Aug 11
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.